Docetaxel, capecitabine and carboplatin in metastatic esophagogastric cancer: a phase II study.
Evans D, Miner T, Iannitti D, Akerman P, Cruff D, Maia-Acuna C, Harrington D, Habr F, Chauhan B, Berkenblit A, Stuart K, Sears D, Kennedy T, Safran H.
Evans D, et al. Among authors: miner t.
Cancer Invest. 2007 Sep;25(6):445-8. doi: 10.1080/07357900701358025.
Cancer Invest. 2007.
PMID: 17882656
Clinical Trial.